ScTIL210
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ScTIL210, covering 2023-04-12 to 2023-04-12. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors [Phase 1, Phase 2]